Author

S.-L. Chan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

B. Wang· 1 shared B. Zhu· 1 shared D. B. Cowan· 1 shared H. Chen· 1 shared J. Bischoff· 1 shared K. Cui· 1 shared M. Du· 1 shared M. F. Linton· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

B. Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Epsins to Inhibit FGF Signaling while Potentiating TGF-beta Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis

Y. Dong, B. Wang, M. Du, B. Zhu, K. Cui, S.-L. Chan, D. B. Cowan, S. Bhattacharjee, S. Wong, J. Bischoff, M. F. Linton, H. Chen

This study identifies epsins as promoters of endothelial-to-mesenchymal transition in atherosclerosis and shows that a therapeutic peptide targeting epsin-FGFR1 interaction reduces EndoMT and atherosclerosis progression.

bioRxiv · Aug 9, 2022 · PreprintCell Biology